SUBSTITUTED OXOPYRIDINE DERIVATIVES AND USE THEREOF AS FACTOR XIA/PLASMA
World Intellectual Property Organization Patent
Stats

Importance

WO Family Size
|
Non-US Coverage
|
Abstract
The invention relates to substituted oxopyridine derivatives of formula (I), in which n stands for the number 1 or 2, A stands for -N(R2)- or -CH2-, R1 stands for a group of formula (II), R3 and R4 stand for hydrogen, and R5 stands for a group of formula (III) or (IV), methods for producing said substituted oxopyridine derivatives, and use of said substituted oxopyridine derivatives to produce drugs for treating and/or preventing diseases, in particular cardiovascular diseases, preferably thrombotic or thromboembolic diseases, and edemas and ophthalmologic diseases.

First Claim
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Country Designations

Patent Owner(s)
Patent Owner | Address |
---|---|
BAYER PHARMA AG | DELEVERKUSEN GERMANY LEVERKUSEN NORTH RHINE-WESTPHALIA |
International Classification(s)

- [Classification Symbol]
- [Patents Count]
Inventor(s)
Inventor Name | Address |
---|---|
SCHLEMMER KARL-HEINZ | WUPPERTAL |
STRASSBURGER JULIA | 42115 WUPPERTAL |
ROHRIG SUSANNE | HILDEN |
SCHMIDT MARTINA VICTORIA | 51063 KÖLN |
TERSTEEGEN ADRIAN | 42111 WUPPERTAL |
GERDES CHRISTOPH | 51063 KÖLN |
BUCHMULLER ANJA | 45259 ESSEN |
SCHAFER MARTINA | 13465 BERLIN |
HILLISCH ALEXANDER | 42651 SOLINGEN |
HEITMEIER STEFAN | 42489 WÜLFRATH |
TELLER HENRIK | 18258 SCHWAAN |
Cited Art Landscape
- No Cited Art to Display

Full Text

Legal Events

Matter Detail

Renewals Detail

Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:

Add to additional portfolios:

Note
The template below is formatted to ensure compatibility with our system.
Provide tags with | separated like (tags1|tags2).
Maximum length is 128 characters for Customer Application No
Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.
Acceptable Date Format - 'MM/DD/YYYY'.
Acceptable Filing/App Types -
- Continuation/Divisional
- Original
- Paris Convention
- PCT National
- With Priority
- EP Validation
- Provisional Conversion
- Reissue
- Provisional
- Foreign Extension
Acceptable Status -
- Pending
- Abandoned
- Unfiled
- Expired
- Granted
Acceptable Matter Types -
- Patent
- Utility Model
- Supplemental Protection Certificate
- Design
- Inventor Certificate
- Plant
- Statutory Invention Reg
Advertisement
Advertisement
Advertisement

Recipient Email Address

Recipient Email Address

Comment
Recipient Email Address

Success
E-mail has been sent successfully.
Failure
Some error occured while sending email. Please check e-mail and try again!
Important Notes on Latency of Status data
This Status indicator is an estimation based on the relevant document kind code. As such, it status will only indicate "Published" or "Granted". Expired, lapsed or abandoned statuses are not available in this release. Please refer to the legal status information for more information.
This status should not be taken as legal conclusion. No representations are made as to the accuracy of the status provided. Please consult a legal professional before relying on this status information.
Important Note on Priority Date data
This priority date is an estimated earliest priority date and is purely an estimation. This date should not be taken as legal conclusion. No representations are made as to the accuracy of the date listed. Please consult a legal professional before relying on this date.
Only for Granted EP cases
EP validations represent the countries in which the EP patent may be in force. Data is based on reporting from the various EP contracting states. The reporting consistency can vary across the countries.